Al Jazeera is conducting a national CVS test to help doctors who use the CVS, which is the world’s largest pharmacy chain, to determine if they are fit to prescribe the drug, according to the company.
Al Jazeera said in a statement that the test is being conducted by the Centers for Disease Control and Prevention.
In a letter to customers on Wednesday, the US Food and Drug Administration (FDA) said it would “take appropriate action” against CVS if it fails to comply with the requirements.
The letter said that CVS had been asked to provide the test by a federal regulator in May, and that CVC had failed to provide a response to the FDA request by the end of June.CVS said it will conduct its own tests to confirm the test results.
The US Food & Drug Administration said it had received no reports of adverse events associated with the CVC test.CVC has said the test was not mandatory.
It has said that it is not involved in CVS’ business, and it does not provide testing to other pharmacy chains.
It is also not the first time CVS has been targeted by health authorities for its decision to discontinue the CVRV, which was originally developed to treat the virus in people with HIV, hepatitis B and other conditions.
CVS stopped selling the drug in October, after a number of patients developed complications from it.
At the time, CVS said that the drug had not shown any effect on people with certain chronic conditions.
The company has since expanded the CVA test to include a new strain of the virus.